CoChat

A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 11 of the 42 sources its claims cite were checked for support.

Abstract

Genome-wide association studies have identified 19p13.3 locus associated with primary biliary cholangitis (PBC). Here we aim to identify causative variant(s) and initiate efforts to define the mechanism by which the 19p13.3 locus variant(s) contributes to the pathogenesis of PBC. A genome-wide meta-analysis of 1931 PBC subjects and 7852 controls in two Han Chinese cohorts confirms the strong association between 19p13.3 locus and PBC. By integrating functional annotations, luciferase reporter assay and allele-specific chromatin immunoprecipitation, we prioritize rs2238574, an AT-Rich Interaction Domain 3A (ARID3A) intronic variant, as a potential causal variant at 19p13.3 locus. The risk allele of rs2238574 shows higher binding affinity of transcription factors, leading to an increased enhancer activity in myeloid cells. Genome-editing demonstrates the regulatory effect of rs2238574 on ARID3A expression through allele-specific enhancer activity. Furthermore, knock-down of ARID3A inhibits myeloid differentiation and activation pathway, and overexpression of the gene has the opposite effect. Finally, we find ARID3A expression and rs2238574 genotypes linked to disease severity in PBC. Our work provides several lines of evidence that a non-coding variant regulates ARID3A expression, presenting a mechanistic basis for association of 19p13.3 locus with the susceptibility to PBC.

Overview

CoChat Summary

TL;DR

A genome-wide meta-analysis in Han Chinese cohorts confirms the 19p13.3 locus in primary biliary cholangitis (PBC), and functional work prioritizes the ARID3A intronic variant rs2238574 as a likely causal regulatory SNP. The risk allele increases enhancer activity and transcription factor binding, upregulates ARID3A in myeloid cells, and is linked to PBC disease severity.

Key findings

  • Meta-analysis of 1,931 PBC subjects and 7,852 controls confirmed strong association at 19p13.3 (rs2238571: OR = 0.77, p = 5.24 × 10−10), with no secondary signal after conditional analysis.
  • rs2238574, an ARID3A intronic variant, was prioritized: its risk allele showed higher enhancer activity in HEK293T and K562 cells, and allele-specific ChIP showed preferential binding of PPARG, NR2F1, and NR2C2 to the risk allele in K562 cells and primary human CD14+ monocytes.
  • CRISPR/Cas9-edited K562 cells with C/C genotype had increased ARID3A expression, higher PPARG/NR2F1/NR2C2 occupancy, lower CD117, and higher CD33 than A/A cells; ARID3A knockdown downregulated myeloid differentiation/activation pathways and reduced BATF2/SPI1, while overexpression increased BATF2/SPI1.
  • In PBC, hepatic ARID3A-positive inflammatory cells correlated with inflammation grade (r = 0.6811, p < 0.001), fibrosis stage (r = 0.4793, p < 0.001), AST (r = 0.3245, p = 0.0035), ALP (r = 0.3007, p = 0.0067), GGT (r = 0.3608, p = 0.0010), and IgM (r = 0.2841, p = 0.0117); the rs2238574 C risk allele was associated with higher liver fibrosis stage after correcting for disease history, but not with inflammation grade.

Methods

  • Two independent Han Chinese PBC cohorts were genotyped and meta-analyzed: cohort 1 had 1,121 cases and 5,467 controls; cohort 2 had 820 cases and 3,194 controls, yielding 1,931 cases and 7,852 controls after quality control. Imputation used 1000 Genomes phase 3, and association used logistic regression with age, sex, and ten principal components, followed by inverse-variance fixed-effects meta-analysis.
  • Functional annotation integrated Haploreg, rSNPBase, RegulomeDB, ENCODE, GTEx eQTL, and Hi-C data. Candidate variant effects were tested by luciferase enhancer reporter assays, ChIP-qPCR, allele-specific ChIP-qPCR, Sanger sequencing, and CRISPR/Cas9 prime editing in K562 cells.
  • ARID3A function was studied by lentiviral shRNA knockdown and overexpression in K562 cells, RNA-seq/GSEA, qPCR, flow cytometry for CD33/CD117/CD68, and monocyte-derived macrophages. Clinical analyses used liver biopsies from 89 PBC, 42 AIH, 20 CHB, and 10 healthy controls, plus whole-blood transcriptome data from 90 PBC and 47 healthy controls.

Limitations

  • The paper states that additional variants at this locus may also affect disease phenotype, and it cannot exclude additional or alternate causal hypotheses.
  • The paper states that functional relevance of 19p13.3 and ARID3A was investigated only in a limited number of clinical samples, and larger sample sizes are needed for clinical correlations.
  • The paper states that genetically engineered mouse models are warranted to further explore the role of ARID3A variants in PBC; evident from the text, the mechanistic work relies heavily on cell lines and in vitro assays, with limited in vivo validation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-023-37213-5

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Meta-analysis of PBC association at 19p13.3. A Regional association plot for 19p13.3 centering on the independent SNP, rs2238571 (purple diamond). B Regional association plot showing the association between genetic variants and PBC at 19p13.3 after conditioning on the lead SNP.
Fig. 1 Meta-analysis of PBC association at 19p13.3. A Regional association plot for 19p13.3 centering on the independent SNP, rs2238571 (purple diamond). B Regional association plot showing the association between genetic variants and PBC at 19p13.3 after conditioning on the lead SNP.CC BY · PubMed Central
Fig. 2 Rs2238574 is a putative regulator of ARID3A expression. A UCSC Genome Browser views of chromatin state of 19p13.3. B Annotation of 20 candidate variants, the size and color of the triangle and/or circle is proportional to annotation data. C Association between rs2238574 genotypes and expression of ARID3A in EBV-transformed lymphocytes (CC, n = 30; CA, n = 80; AA, n = 37). Source data are derived from GTEx. D Three-dimensional chromatin interactions for the ARID3A locus in K562 cells. Source data are derived from 3D Genome Browser. E Luciferase reporter assay in HEK293T and K562 cells transfected with pGL3 plasmids containing rs2238574. Luciferase signals are normalized to Renilla signals. Data are representative of three independent experiments (Mean ± SD for quadruplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001.
Fig. 2 Rs2238574 is a putative regulator of ARID3A expression. A UCSC Genome Browser views of chromatin state of 19p13.3. B Annotation of 20 candidate variants, the size and color of the triangle and/or circle is proportional to annotation data. C Association between rs2238574 genotypes and expression of ARID3A in EBV-transformed lymphocytes (CC, n = 30; CA, n = 80; AA, n = 37). Source data are derived from GTEx. D Three-dimensional chromatin interactions for the ARID3A locus in K562 cells. Source data are derived from 3D Genome Browser. E Luciferase reporter assay in HEK293T and K562 cells transfected with pGL3 plasmids containing rs2238574. Luciferase signals are normalized to Renilla signals. Data are representative of three independent experiments (Mean ± SD for quadruplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001.CC BY · PubMed Central
Fig. 3 The risk allele of rs2238574 enhances the chromatin binding of transcription factors. A, B ChIP-qPCR confirmation of the enrichment of active enhancer marks at rs2238574-containing region in K562 cells and human CD14+ monocytes. C Motif analysis suggests that rs2238574 resides within DNA-binding motifs of PPARG, NR2F1 and NR2C2. D ChIP-qPCR results showing enrichment of PPARG, NR2F1 and NR2C2 at the rs2238574-containing region in K562 cells. E ChIP-AS-qPCR showing allele-specific binding of PPARG, NR2F1 and NR2C2 at rs2238574 in K562 cells. F ChIP-qPCR results showing enrichment of PPARG, NR2C2 and NR2F1 at the rs2238574-containing region in human CD14+ monocytes. G ChIP-AS-qPCR showing allele-specific binding of PPARG, NR2C2 and NR2F1 at rs2238574 in human CD14+ monocytes. H Sanger sequencing chromatograms of the SNP region from the input and ChIPed DNA in human CD14+ monocytes. Data are representative of three independent experiments (Mean ± SD for triplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001.
Fig. 3 The risk allele of rs2238574 enhances the chromatin binding of transcription factors. A, B ChIP-qPCR confirmation of the enrichment of active enhancer marks at rs2238574-containing region in K562 cells and human CD14+ monocytes. C Motif analysis suggests that rs2238574 resides within DNA-binding motifs of PPARG, NR2F1 and NR2C2. D ChIP-qPCR results showing enrichment of PPARG, NR2F1 and NR2C2 at the rs2238574-containing region in K562 cells. E ChIP-AS-qPCR showing allele-specific binding of PPARG, NR2F1 and NR2C2 at rs2238574 in K562 cells. F ChIP-qPCR results showing enrichment of PPARG, NR2C2 and NR2F1 at the rs2238574-containing region in human CD14+ monocytes. G ChIP-AS-qPCR showing allele-specific binding of PPARG, NR2C2 and NR2F1 at rs2238574 in human CD14+ monocytes. H Sanger sequencing chromatograms of the SNP region from the input and ChIPed DNA in human CD14+ monocytes. Data are representative of three independent experiments (Mean ± SD for triplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001.CC BY · PubMed Central
Fig. 4 ARID3A contributes to the differentiation of myeloid cells. A GSEA showing the myeloid differentiation pathway and myeloid activation pathway were downregulated in ARID3A knock-down K562 cells. B Heatmap of differentially expressed genes related to myeloid differentiation pathway and myeloid activation pathway in ARID3A knock-down K562 cells (three replicates). C ARID3A ChIP-seq signals at the promoter region of BATF2 and SPI1 in K562 cells. Source data are derived from ENCODE. D ChIP-qPCR confirmation of the enrichment of ARID3A at the promoter region of BATF2 and SPI1 in K562 cells. E Increased expression of ARID3A after ARID3A plasmid overexpression in K562 cells. F Relative expression of BATF2 and SPI1 after ARID3A plasmid overexpression in K562 cells. G Flow cytometric measurement of surface antigen CD117 and CD33 after knock-down of ARID3A in K562 cells. Data are representative of three independent experiments (Mean ± SD for triplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001. MFI mean fluorescence intensity.
Fig. 4 ARID3A contributes to the differentiation of myeloid cells. A GSEA showing the myeloid differentiation pathway and myeloid activation pathway were downregulated in ARID3A knock-down K562 cells. B Heatmap of differentially expressed genes related to myeloid differentiation pathway and myeloid activation pathway in ARID3A knock-down K562 cells (three replicates). C ARID3A ChIP-seq signals at the promoter region of BATF2 and SPI1 in K562 cells. Source data are derived from ENCODE. D ChIP-qPCR confirmation of the enrichment of ARID3A at the promoter region of BATF2 and SPI1 in K562 cells. E Increased expression of ARID3A after ARID3A plasmid overexpression in K562 cells. F Relative expression of BATF2 and SPI1 after ARID3A plasmid overexpression in K562 cells. G Flow cytometric measurement of surface antigen CD117 and CD33 after knock-down of ARID3A in K562 cells. Data are representative of three independent experiments (Mean ± SD for triplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001. MFI mean fluorescence intensity.CC BY · PubMed Central
Fig. 5 Effects of rs2238574 genotypes on ARID3A expression in K562 cells. A Sanger sequencing of CRISPR/Cas9-modified and parental K562 cells. B Relative expression of ARID3A in mutated and parental K562 cells (C/C, n = 9; C/A, n = 7; A/A, n = 15). C ChIP-qPCR results showing different enrichment of PPARG, NR2F1 and NR2C2 at the rs2238574-containing region between C/C and A/A K562 cells (n = 3, biologically independent samples). D Flow cytometric measurement of surface antigen CD117 and CD33 in C/C and A/A K562 cells. Data are representative of three independent experiments (Mean ± SD for quadruplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001. MFI mean fluorescence intensity.
Fig. 5 Effects of rs2238574 genotypes on ARID3A expression in K562 cells. A Sanger sequencing of CRISPR/Cas9-modified and parental K562 cells. B Relative expression of ARID3A in mutated and parental K562 cells (C/C, n = 9; C/A, n = 7; A/A, n = 15). C ChIP-qPCR results showing different enrichment of PPARG, NR2F1 and NR2C2 at the rs2238574-containing region between C/C and A/A K562 cells (n = 3, biologically independent samples). D Flow cytometric measurement of surface antigen CD117 and CD33 in C/C and A/A K562 cells. Data are representative of three independent experiments (Mean ± SD for quadruplicates). P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001. MFI mean fluorescence intensity.CC BY · PubMed Central
Fig. 6 Increased ARID3A expression in PBC. A, B Representative immunohistochemical staining (x200; x400) and statistical analysis of ARID3A in HC (n = 10), PBC (n = 89), AIH (n = 42) and CHB (n = 20) patients. C Increased ARID3A expression in whole blood from PBC patients (HC, n = 47; PBC, n = 90). D Representative confocal staining of CD33 (in green), ARID3A (in red) and DAPI (for nuclei in blue) in the PBC liver (n = 10). E Representative confocal staining of CD11b (in green), ARID3A (in red) and DAPI (for nuclei in blue) in the PBC liver (n = 10). Data are represented as mean ± SD. P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001. Scale bars, 20 μm. HC healthy control, AIH autoimmune hepatitis, CHB chronic hepatitis B.
Fig. 6 Increased ARID3A expression in PBC. A, B Representative immunohistochemical staining (x200; x400) and statistical analysis of ARID3A in HC (n = 10), PBC (n = 89), AIH (n = 42) and CHB (n = 20) patients. C Increased ARID3A expression in whole blood from PBC patients (HC, n = 47; PBC, n = 90). D Representative confocal staining of CD33 (in green), ARID3A (in red) and DAPI (for nuclei in blue) in the PBC liver (n = 10). E Representative confocal staining of CD11b (in green), ARID3A (in red) and DAPI (for nuclei in blue) in the PBC liver (n = 10). Data are represented as mean ± SD. P values are calculated using unpaired two-tailed Student’s t test and indicated significant if *p < 0.05, **p < 0.01, or ***p < 0.001. Scale bars, 20 μm. HC healthy control, AIH autoimmune hepatitis, CHB chronic hepatitis B.CC BY · PubMed Central
Fig. 7 ARID3A expression and rs2238574 genotypes are associated with disease severity. A Association of the numbers of hepatic ARID3A positive inflammation cells with hepatic inflammatory degrees (left) and fibrosis stages (right) in PBC patients. B Association of the numbers of hepatic ARID3A positive inflammation cells with serum ALT, AST, GGT, ALP, TBil, ALB, IgG and IgM levels. Association analysis are performed using Pearson’s correlation. C Association of rs2238574 genotypes with liver fibrosis (left) and inflammation (right) in subjects with PBC (C/C, n = 66; C/A, n = 113; A/A, n = 32). Correlation analysis are performed using logistic regression adjusted for disease history. ALT Alanine aminotransferase, AST aspartate transaminase, ALP alkaline phosphatase, GGT γ-Glutamyl transferase, TBil Total bilirubin, ALB albumin, IgG immunoglobulin G, IgM immunoglobulin M.
Fig. 7 ARID3A expression and rs2238574 genotypes are associated with disease severity. A Association of the numbers of hepatic ARID3A positive inflammation cells with hepatic inflammatory degrees (left) and fibrosis stages (right) in PBC patients. B Association of the numbers of hepatic ARID3A positive inflammation cells with serum ALT, AST, GGT, ALP, TBil, ALB, IgG and IgM levels. Association analysis are performed using Pearson’s correlation. C Association of rs2238574 genotypes with liver fibrosis (left) and inflammation (right) in subjects with PBC (C/C, n = 66; C/A, n = 113; A/A, n = 32). Correlation analysis are performed using logistic regression adjusted for disease history. ALT Alanine aminotransferase, AST aspartate transaminase, ALP alkaline phosphatase, GGT γ-Glutamyl transferase, TBil Total bilirubin, ALB albumin, IgG immunoglobulin G, IgM immunoglobulin M.CC BY · PubMed Central
Fig. 8 Graphical representation of the regulation and function of 19p13.3 in PBC. HC healthy control, ChIP chromatin immunoprecipitation, TF transcription factor.
Fig. 8 Graphical representation of the regulation and function of 19p13.3 in PBC. HC healthy control, ChIP chromatin immunoprecipitation, TF transcription factor.CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 3 Not valid · 15 Not checked · 57 Own results and interpretations

45 more claims

Create a free account to see all 80 claims and to verify the 31 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 20

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 56 references

Cited by

See all 18

Metadata

Authors
Li, Y., Li, Z., Chen, R., Lian, M., Wang, H., Wei, Y., You, Z., Zhang, J., Li, B., Li, Y., Huang, B., Chen, Y., Liu, Q., Lyu, Z., Liang, X., Miao, Q., Xiao, X., Wang, Q., Fang, J., Shi, Y., Liu, X., Seldin, M. F., Gershwin, M. E., Tang, R., & Ma, X.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Qingdao University (CN)
  • Southeast University (CN)
  • University of California, Davis (US)
Corresponding author
  • Gershwin, M. Eric
  • Tang, Ruqi
  • Ma, Xiong
Venue
Nature Communications
Published
2023-03-28
Volume
14
Issue
1
Pages
1732-1732
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4361216327
Cited by
18
References
56
Citations by year
2026: 1 · 2025: 6 · 2024: 7 · 2023: 4
FWCI
0.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81922010, 82070583, 81873561, 81570469, 81830016, 81620108002, 81922010, 81873561 and 81570469, 81771732, 81800504)
  • Shanghai Education Development Foundation (20XD1422500)
  • Shanghai Municipal Education Commission
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
primary biliary cirrhosis, ARID3A, regulatory variants, non-coding variants, enhancer activity, transcription factor binding, myeloid cells, disease susceptibility, disease severity, Han Chinese
MeSH terms
DNA-Binding Proteins, Genotype, Humans, Liver Cirrhosis, Biliary, Transcription Factors, Genetic Predisposition to Disease, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression. https://app.cochat.ai/papers/10.1038/s41467-023-37213-5
The paper
Li, Y., Li, Z., Chen, R., Lian, M., Wang, H., Wei, Y., You, Z., Zhang, J., Li, B., Li, Y., Huang, B., Chen, Y., Liu, Q., Lyu, Z., Liang, X., Miao, Q., Xiao, X., Wang, Q., Fang, J., . . . Ma, X. (2023). A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression. Nature Communications. https://doi.org/10.1038/s41467-023-37213-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.